TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)

Taiwan · Delayed Price · Currency is TWD

8.99

-0.18 (-1.96%)

Sep 8, 2026, 12:19 PM CST

TPEX:4157 Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	256.46	259.47	150.65	123.13	36.23	1,295
Revenue Growth	530.40%	72.23%	22.35%	239.87%	-97.20%	5426.95%
Gross Profit	240.28	241.3	134.52	111.69	32.49	1,282
Operating Income	82.67	69.4	-122.1	-174.7	-277.67	899.46
Net Income	155.12	45.18	-38.58	136.73	-237.16	775.62
Earnings Per Share	0.22	0.06	-0.05	0.19	-0.33	1.08
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Research and Development of New Drugs	259.42	149.15	119.15	36.23	1,295
The Others	0.06	1.5	3.99	-	-
Total	259.47	150.65	123.13	36.23	1,295

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	915.27	1,027	1,020	1,038	898.6	924.4
Total Debt	11.43	49.22	58.71	74.69	38.47	53.46
Net Cash (Debt)	903.84	977.54	961.11	963.3	860.13	870.94
Net Cash Growth	9.11%	1.71%	-0.23%	12.00%	-1.24%	177.67%
Net Cash Per Share	1.28	1.37	1.34	1.34	1.20	1.21

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	53.48	20.93	-173.09	7.46	-21.27	629.07
Capital Expenditures	-1.59	-1.45	-0.53	-3.89	-3.39	-10.24
Free Cash Flow	51.89	19.48	-173.62	3.57	-24.66	618.83
Free Cash Flow Growth	-38.48%	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	93.69%	93.00%	89.29%	90.70%	89.69%	99.02%
Operating Margin	32.24%	26.74%	-81.05%	-141.88%	-766.41%	69.48%
Pretax Margin	65.51%	22.14%	-21.83%	116.53%	-634.18%	67.67%
Profit Margin	60.48%	17.41%	-25.61%	111.04%	-654.61%	59.91%
FCF Margin	20.23%	7.51%	-115.25%	2.90%	-68.06%	47.80%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	42.48	211.13	-	79.80	-	14.23
Forward PE	-	27.83	27.83	27.83	27.83	27.83
P/FCF Ratio	125.79	489.64	-	3055.51	-	17.84
PS Ratio	25.45	36.76	54.56	88.61	317.56	8.53